Most biopharmaceuticals use cloud-based infrastructure at some level. But just how “cloudy” is your business? Many companies are in a hybrid state, on a path from traditional on-premise infrastructure to operating fully in the cloud. That journey can feel arduous, and it may seem easier to pause along the way. But a truly cloud-only approach to biopharmaceutical lifecycle management has the potential to radically accelerate the biopharma lifecycle. This objective is non-negotiable, as many software vendors provide new features only to the cloud and offer only critical updates for their on-premise offering.
Figure 1. Diagram illustrating traditional on-premise infrastructure to operating fully in the cloud. [Courtesy of IDBS.]
Organizations that are moving from an on-premise solution might start their cloud journey with foundational infrastructure, like a co-located data center or cloud-based hosting.…